LOC01:55
22:55 GMT
WASHINGTON, June 11 (KUNA) -- The US Food and Drug Administration (FDA) on Friday said that a number of Janssen COVID-19 vaccine batches are not suitable for use, due to contamination concerns at Baltimore plant.
In a statement, the FDA said that it allowed Johnson & Johnson to distribute two batches of the vaccine, while millions of doses will be thrown out.
According to The New York Times, over 60 million doses were unusable, while another 10 million doses from the plant will be allowed to be distributed but with a warning that the FDA cannot guarantee they were produced using good manufacturing practices.
Janssen Pharmaceuticals is owned by Johnson & Johnson. (end)
asj.mys